🏛️ Verified NIH Record • Updated 2025-09-16
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (NCT00608764)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Brigham and Women's Hospital
🩺 Plain-English Summary (8th-Grade Level)
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is often caused by cigarette smoking. The purpose of this study is to evaluate whether certain genetic factors predispose some smokers to develop COPD more than others.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 45 Years to 80 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (20 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- University of California at San Diego — San Diego, California
- Los Angeles Biomedical Research Institute — Torrance, California
- National Jewish Health — Denver, Colorado
- Morehouse School of Medicine — Atlanta, Georgia
- University of Iowa — Iowa City, Iowa
- Johns Hopkins University — Baltimore, Maryland
- Brigham and Women's Hospital — Boston, Massachusetts
- Reliant Medical Group — Worcester, Massachusetts
- Ann Arbor VA Medical Center — Ann Arbor, Michigan
- University of Michigan — Ann Arbor, Michigan
- Minneapolis VA Medical Center — Minneapolis, Minnesota
- HealthPartners Research Foundation — Minneapolis, Minnesota
- University of Minnesota — Minneapolis, Minnesota
- Columbia University Medical Center — New York, New York
- Duke University — Durham, North Carolina
- Temple University — Philadelphia, Pennsylvania
- University of Pittsburgh — Pittsburgh, Pennsylvania
- Baylor College of Medicine — Houston, Texas
- University of Texas Health Sciences Center at San Antonio — San Antonio, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pulmonary Disease, Chronic Obstructive
- A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease — Yuma, Arizona
- Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent — Rochester, Minnesota
- Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD — Minneapolis, Minnesota
- Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting — Mississauga,
- Innate Immunity in Ozone-induced Airway Inflammation in COPD — San Francisco, California
Explore by condition: All Pulmonary Disease, Chronic Obstructive clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.